Pilot Study of Human Tear Proteins
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00453258 |
Recruitment Status
:
Terminated
(Stopped due to low enrollment)
First Posted
: March 28, 2007
Last Update Posted
: January 17, 2013
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Eye Disease | Other: Eye Examination |
Study Type : | Observational |
Actual Enrollment : | 63 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Analysis of Human Tear Proteins: A Pilot Study to Describe the Tear Film Proteome of Patients Undergoing Ophthalmic Examination. |
Study Start Date : | February 2007 |
Actual Primary Completion Date : | September 2011 |
Actual Study Completion Date : | September 2011 |
Group/Cohort | Intervention/treatment |
---|---|
Study Subject
Subjects receiving eye examination
|
Other: Eye Examination
Subjects receiving eye examination
|
- Plan Prospective Research [ Time Frame: Throughout study participation ]Pilot study will provide data to plan prospective research to better delineate the utility of tear proteins in diagnosing and following disease status in a non-invasive fashion.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Senior) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- 18 years of age and older
- able to cooperate with tear sample collection
- provide written informed consent
Exclusion Criteria:
- special populations (children, pregnant or lactating females, prisoners, etc)
- refusal to sign sudy consent

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00453258
United States, Colorado | |
Rocky Mountain Lions Eye Institute | |
Aurora, Colorado, United States, 80045 |
Principal Investigator: | Malik Y. Kahook, MD | Rocky Mountain Lions Eye Institute |
Responsible Party: | University of Colorado, Denver |
ClinicalTrials.gov Identifier: | NCT00453258 History of Changes |
Other Study ID Numbers: |
06-0862 |
First Posted: | March 28, 2007 Key Record Dates |
Last Update Posted: | January 17, 2013 |
Last Verified: | October 2012 |
Keywords provided by University of Colorado, Denver:
ocular proteomics eye disease proteomics |
Additional relevant MeSH terms:
Eye Diseases |